Identification of bioactive peptides from a papain hydrolysate of bovine serum albumin and assessment of an antihypertensive effect in spontaneously hypertensive rats

Food Research International

Volumn 81, Issue , 2016, Pages 91-99

  Lafarga, Tomas ^a   Aluko, Rotimi E ^b   Rai, Dilip K ^a   O'Connor, Paula ^a   Hayes, Maria ^a  

^a TEAGASC   (Ireland)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ACE I; Bioactive peptides; Hypertension; Renin; Serum albumin; Spontaneously hypertensive rats

Indexed keywords

BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MAMMALS; PAPAIN; PEPTIDES; PROTEINS; RATS; SURFACE PLASMON RESONANCE;

BIOACTIVE PEPTIDES; HYPERTENSION; RENIN; SERUM ALBUMIN; SPONTANEOUSLY HYPERTENSIVE RATS;

BODY FLUIDS;

EID: 84954484848     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2016.01.007     Document Type: Article

References (41)

1. Álvarez C., Bances M., Rendueles M., Díaz M. Functional properties of isolated porcine blood proteins. International Journal of Food Science and Technology 2009, 44(4):807-814. 10.1111/j.1365-2621.2009.01908.x.
2. Bah C.S.F., Bekhit A.E.-D.A., Carne A., McConnell M.A. Slaughterhouse blood: An emerging source of bioactive compounds. Comprehensive Reviews in Food Science and Food Safety 2013, 12(3):314-331. 10.1111/1541-4337.12013.
3. De Meester I., Lambeir A.-M., Proost P., Scharpé S. Dipeptidyl peptidase IV substrates. Dipeptidyl aminopeptidases in health and disease 2003, Vol. 524:3-17. Springer, US. N. Back, I. Cohen, D. Kritchevsky, A. Lajtha, R. Paoletti (Eds.).
4. Di Bernardini R., Mullen A.M., Bolton D., Kerry J., O'Neill E., Hayes M. Assessment of the angiotensin-I-converting enzyme (ACE-I) inhibitory and antioxidant activities of hydrolysates of bovine brisket sarcoplasmic proteins produced by papain and characterisation of associated bioactive peptidic fractions. Meat Science 2012, 90(1):226-235. doi:10.1016/j.meatsci.2011.07.008.
5. Drucker D.J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003, 26(10):2929-2940. 10.2337/diacare.26.10.2929.
6. EFSA Scientific opinion on the substantiation of a health claim related to isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) and maintenance of normal blood pressure pursuant to Article 13(5) of Regulation (EC) No. 1924/2006. EFSA Journal 2011, 9(9):18.
7. Fitzgerald C., Mora-Soler L., Gallagher E., O'Connor P., Prieto J., Soler-Vila A., Hayes M. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. Journal of Agricultural and Food Chemistry 2012, 60(30):7421-7427. 10.1021/jf301361c.
8. Fitzgerald C., Aluko R.E., Hossain M., Rai D.K., Hayes M. Potential of a renin inhibitory peptide from the red seaweed Palmaria palmata as a functional food ingredient following confirmation and characterization of a hypotensive effect in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2014, 62(33):8352-8356. 10.1021/jf500983n.
9. Fulop T., Tessier D., Carpentier A. The metabolic syndrome. Pathologie Biologie 2006, 54(7):375-386. 10.1016/j.patbio.2006.07.002.
10. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Research 2003, 31(13):3784-3788. 10.1093/nar/gkg563.
11. Girgih A., Udenigwe C., Li H., Adebiyi A., Aluko R. Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. Journal of the American Oil Chemists' Society 2011, 88(11):1767-1774. 10.1007/s11746-011-1841-9.
12. Hazato T., Kase R. Isolation of angiotensin-converting enzyme inhibitor from porcine plasma. Biochemical and Biophysical Research Communications 1986, 139(1):52-55. doi:10.1016/S0006-291X(86)80078-X.
13. He R., Alashi A., Malomo S.A., Girgih A.T., Chao D., Ju X., Aluko R.E. Antihypertensive and free radical scavenging properties of enzymatic rapeseed protein hydrolysates. Food Chemistry 2013, 141(1):153-159. 10.1016/j.foodchem.2013.02.087.
14. Hyun C.K., Shin H.K. Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochemistry 2000, 36(1-2):65-71. 10.1016/S0032-9592(00)00176-X.
15. Jamdar S.N., Rajalakshmi V., Pednekar M.D., Juan F., Yardi V., Sharma A. Influence of degree of hydrolysis on functional properties, antioxidant activity and ACE inhibitory activity of peanut protein hydrolysate. Food Chemistry 2010, 121(1):178-184. 10.1016/j.foodchem.2009.12.027.
16. Koibuchi N., Hasegawa Y., Katayama T., Toyama K., Uekawa K., Sueta T., Lin B. DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure. Cardiovascular Diabetology 2014, 13:154. 10.1186/s12933-014-0157-0.
17. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 2006, 16(9):945-960. doi:10.1016/j.idairyj.2005.10.012.
18. Lacroix I.M.E., Li-Chan E.C.Y. Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. Journal of Functional Foods 2012, 4(2):403-422. doi:10.1016/j.jff.2012.01.008.
19. Lafarga T., Hayes M. Bioactive peptides from meat muscle and by-products: Generation, functionality and application as functional ingredients. Meat Science 2014, 98(2):227-239. 10.1016/j.meatsci.2014.05.036.
20. Lafarga T., O'Connor P., Hayes M. Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides 2014, 59:53-62. doi:10.1016/j.peptides.2014.07.005.
21. Lafarga T., Rai D.K., O'Connor P., Hayes M. A bovine fibrinogen-enriched fraction as a source of peptides with in vitro renin and angiotensin-I-converting enzyme inhibitory activities. Journal of Agricultural and Food Chemistry 2015, 63(39):8676-8684. 10.1021/acs.jafc.5b03167.
22. Lan V.T.T., Ito K., Ohno M., Motoyama T., Ito S., Kawarasaki Y. Analyzing a dipeptide library to identify human dipeptidyl peptidase IV inhibitor. Food Chemistry 2015, 175:66-73. 10.1016/j.foodchem.2014.11.131.
23. Li H., Aluko R.E. Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. Journal of Agricultural and Food Chemistry 2010, 58(21):11471-11476. 10.1021/jf204720q.
24. Li H., Prairie N., Udenigwe C.C., Adebiyi A.P., Tappia P.S., Aukema H.M., Aluko R.E. Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. Journal of Agricultural and Food Chemistry 2011, 59(18):9854-9860. 10.1021/jf201911p.
25. Li-Chan E.C.Y., Hunag S.L., Jao C.L., Ho K.P., Hsu K.C. Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. Journal of Agricultural and Food Chemistry 2012, 60(4):973-978.
26. Majumder K., Wu J. Molecular targets of antihypertensive peptides: Understanding the mechanisms of action based on the pathophysiology of hypertension. International Journal of Molecular Sciences 2014, 16(1):256-283. 10.3390/ijms16010256.
27. Matsufuji H., Matsui T., Seki E., Osajima K., Nakashima M., Osajima Y. Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Bioscience, Biotechnology, and Biochemistry 1994, 58(12):2244-2245. 10.1271/bbb.58.2244.
28. Minkiewicz P., Dziuba J., Iwaniak A., Dziuba M., Darewicz M. BIOPEP database and other programs for processing bioactive peptide sequences. Journal of AOAC International 2008, 91(4):965-980.
29. Mooney C., Haslam N.J., Pollastri G., Shields D.C. Towards the improved discovery and design of functional peptides: Common features of diverse classes permit generalized prediction of bioactivity. PLoS ONE 2012, 7(10). 10.1371/journal.pone.0045012.
30. Mora L., Hayes M. Cardioprotective cryptides derived from fish and other food sources: Generation, application, and future markets. Journal of Agricultural and Food Chemistry 2015, 63(5):1319-1331. 10.1021/jf505019z.
31. Mundi S., Aluko R.E. Inhibitory properties of kidney bean protein hydrolysate and its membrane fractions against renin, angiotensin converting enzyme, and free radicals. Austin Journal of Nutrition and Food Sciences 2014, 2(1):11.
32. Ofori J.A., Hsieh Y.-H.P. Issues related to the use of blood in food and animal feed. Critical Reviews in Food Science and Nutrition 2013, 54(5):687-697. 10.1080/10408398.2011.605229.
33. Sentandreu M.A., Toldrá F. Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases. Food Chemistry 2006, 102(2):511-515. doi:10.1016/j.foodchem.2006.04.018.
34. Silveira S.T., Martínez-Maqueda D., Recio I., Hernández-Ledesma B. Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chemistry 2013, 141(2):1072-1077. 10.1016/j.foodchem.2013.03.056.
35. Tanaka K., Sawatani E., Shigueoka E.M., Dias G.A., Nakao H.C., Arashiro F. Isolation of bovine plasma albumin by liquid chromatography and its polymerization for use in immunohematology. Brazilian Journal of Medical and Biological Research 2001, 34(8):977-983.
36. Udenigwe C.C., Lin Y.-S., Hou W.-C., Aluko R.E. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. Journal of Functional Foods 2009, 1(2):199-207. doi:10.1016/j.jff.2009.01.009.
37. Velarde-Salcedo A.J., Barrera-Pacheco A., Lara-González S., Montero-Morán G.M., Díaz-Gois A., González de Mejia E., Barba de la Rosa A.P. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chemistry 2013, 136(2):758-764. doi:10.1016/j.foodchem.2012.08.032.
38. Vermeirssen V., Camp J.V., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92(03):357-366.
39. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of Di- and tripeptides. Journal of Agricultural and Food Chemistry 2006, 54(3):732-738.
40. Xie L., Tong W., Yu D., Xu J., Li J., Gao C. Bovine serum albumin nanoparticles modified with multilayers and aptamers for pH-responsive and targeted anti-cancer drug delivery. Journal of Materials Chemistry 2012, 22(13):6053-6060. 10.1039/C2JM16831F.
41. Yano S., Suzuki K., Funatsu G. Isolation from α-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Bioscience, Biotechnology, and Biochemistry 1996, 60(4):661-663. 10.1271/bbb.60.661.